Avidity Biosciences
RNA
#2609
Rank
NZ$9.24 B
Marketcap
$78.23
Share price
-1.66%
Change (1 day)
753.34%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : NZ$2.17 Billion

According to Avidity Biosciences's latest financial reports the company has NZ$2.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.94 B-2.13%
2022-12-31NZ$0.96 B62.01%
2021-12-31NZ$0.59 B30.55%
2020-12-31NZ$0.45 B223.84%
2019-12-31NZ$0.14 B2948.48%
2018-12-31NZ$4.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.83 B-15.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.68 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.44 B 12.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.62 B-71.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.51 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.89 B 446.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.19 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK